Skip to content

Evaluation of the effects of combined consumption of test foods containing plant-derived bioactive substances on the biomarker in blood

Evaluation of the effects of combined consumption of test foods containing plant-derived bioactive substances on the biomarker in blood - Evaluation of the effects of combined consumption of test foods containing plant-derived bioactive substances on the biomarker in blood

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048976
Enrollment
44
Registered
2022-09-21
Start date
2022-09-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Intake the test food and drink for 3 weeks Intake the placebo food and drink for 3 weeks

Sponsors

KAGOME CO., LTD.
Lead Sponsor
Leverage Brain Inc.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Subjects who are males and females over 20 years old and under 65 years old 2) Subjects who can use the electronic logbook application 3) Subjects who agree to participate in this study with a written informed consent

Exclusion criteria

Exclusion criteria: 1) Those who have factors other than dietary habits that greatly affect blood biomarker concentration (Habitual drinker or smoker, those who have an infectious disease within 1 month of the start of the study, those who take antibiotics within 1 month of the start of the study, those who have chronic digestive disorders) 2) Those who have factors other than blood biomarker concentration that greatly affect appetite (Those who eat less than two meals a day on some days, those who are undergoing hormone therapy [including steroid]) 3) Those who may have adverse events when collecting blood (those who are sensitive to alcohol to the extent that alcohol disinfection is difficult, those who have skin diseases on their fingers, Those who with severe anemia) 4) Those who are unable to draw the required amount of blood (100 microL) at the screening 5) Those who may develop allergies due to ingestion of the test foods 6) Subjects who regularly use medicines, health foods, and supplements (Except for those who can stop taking health foods and supplements approximately one week prior to the start of the study) 7) Those who habitually consume (at least twice a week) foods containing the same active ingredients as the test foods and beverages (Except for those who can reduce the intake of these foods to less than twice a week for both about 1 week prior to the start of the study) 8) Those who participated in other human studies within 1 month of the start of this study 9) Pregnant or lactating women, women who expect to be pregnant during this study or may be pregnant 10) Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator

Design outcomes

Primary

MeasureTime frame
Blood biomarker concentrations

Secondary

MeasureTime frame
Appetite score, nutrient intake

Countries

Japan

Contacts

Public ContactShigeru Imai

Leverage Brain Inc. Clinical Trial Department

imai@levbrain.com080-7290-0404

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026